MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0306101

Медицинская библиотека · PloS one · 2024

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis.

Verboven Lennert, Callens Steven, Black John, Maartens Gary, Dooley Kelly E, Potgieter Samantha, Cartuyvels Ruben, SMARTT team, Laukens Kris, Warren Robin M, Van Rie Annelies

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Rifampicin resistant tuberculosis remains a global health problem with almost half a million new cases annually. In high-income countries patients empirically start a standardized treatment regimen, followed by an individualized regimen guided by drug susceptibility test (DST) results. In most settings, DST information is not available or is limited to isoniazid and fluoroquinolones. Whole genome sequencing could more accurately guide individualized treatment as the full drug resistance profile is obtained with a single test. Whole genome sequencing has not reached its full potential for patient care, in part due to the complexity of translating a resistance profile into the most effective individualized regimen.

METHODS

We developed a treatment recommender clinical decision support system (CDSS) and an accompanying web application for user-friendly recommendation of the optimal individualized treatment regimen to a clinician.

RESULTS

Following expert stakeholder meetings and literature review, nine drug features and 14 treatment regimen features were identified and quantified. Using machine learning, a model was developed to predict the optimal treatment regimen based on a training set of 3895 treatment regimen-expert feedback pairs. The acceptability of the treatment recommender CDSS was assessed as part of a clinical trial and in a routine care setting. Within the clinical trial setting, all patients received the CDSS recommended treatment. In 8 of 20 cases, the initial recommendation was recomputed because of stock out, clinical contra-indication or toxicity. In routine care setting, physicians rejected the treatment recommendation in 7 out of 15 cases because it deviated from the national TB treatment guidelines. A survey indicated that the treatment recommender CDSS is easy to use and useful in clinical practice but requires digital infrastructure support and training.

CONCLUSIONS

Our findings suggest that global implementation of the novel treatment recommender CDSS holds the potential to improve treatment outcomes of patients with RR-TB, especially those with 'difficult-to-treat' forms of RR-TB.

Для цитирования: Verboven Lennert, Callens Steven, Black John, Maartens Gary, Dooley Kelly E, Potgieter Samantha, Cartuyvels Ruben, SMARTT team, Laukens Kris, Warren Robin M, Van Rie Annelies. A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis.. PloS one. 2024. DOI: 10.1371/journal.pone.0306101.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.